Mid-tier biotech and specialty pharmaceutical firms drive real estate demand (Sponsored content)
August 19, 2014 at 14:57 PM EDT
Across North America, real estate activity and demand within the life sciences industry seems to have shifted from one driven by big pharma companies to one where mid-tier companies and specialty players are experiencing overnight growth and highly variable needs in response to promising products and treatments...